Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vir Biotechnology (VIR) just unveiled an update.
Sung Lee will depart from his role as Executive Vice President and CFO of Vir Biotechnology on May 3, 2024, to explore a new career path, sparking a search for his replacement. Meanwhile, the company is bolstering its board with the nomination of two new independent directors, Norbert Bischofberger, Ph.D., and Ramy Farid, Ph.D., for the upcoming Annual Meeting of Stockholders.
See more insights into VIR stock on TipRanks’ Stock Analysis page.